Last update: March 1, 2006


High Risk for breastfeeding

Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives).
Read the Comment.

It is an adrenergic-agonist drug, which is used for obesity treatment. It may be a cause of insomnia, anorexia and irritability.

Breastfeeding women return to pre-pregnancy body weight sooner than bottle-feeding mothers.


We do not have alternatives for Clobenzorex.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Clobenzorex is also known as


Clobenzorex belongs to this group or family:


Main tradenames from several countries containing Clobenzorex in its composition:


Variable Value Unit
Molecular weight 292 daltons


  1. AEMPS Retirada del mercado de los medicamentos anorexígenos de acción central. 2000 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) from Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM